Ahmed, I., & Goldstein, B. J. (2006). Cardiovascular risk in the spectrum of type 2 diabetes mellitus. The Mount Sinai Journal of Medicine, 73(5), 759-768.
Ahren, B., & Pacini, G. (1998). Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. The Journal of Clinical Endocrinology and Metabolism, 83, 3350-3356.
Alberti, K. G., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine : a Journal of the British Diabetic Association, 15(7), 554-557.
Alberti, G., Zimmet, P., & Shaw, J. (2005). A new IDF worldwide definition of the metabolic:
the rationale and the results. Diabetes Voice, 50(3), 31-33.
Aljada, A., Ghanim, H., Assian, E., & Dandona, P. (2002). Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism, 51, 487–491.
Arumugam, T. V., Gleichmann, M., Tang, S. C., & Mattson, M. P. (2006). Hormesis / preconditioning mechanisms, the nervous system and aging. Aging Research Review, 5(2), 165-178.
Arias, E. B., Gosselin, L. E., & Cartee, G. D. (2001). Exercise training eliminates age-related differences in skeletal muscle insulin receptor and IRS-1 abundance in rats. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 56(10), B449-455.
Ascaso, J. F., Romero, P., Real, J. T., Priego, A., Valdecabres, C., & Carmena, R. (2001).
Insulin resistance quantification by fasting insulin plasma values and HOMA index in a
non-diabetic population. Medicina Clinica.(Barc), 117(14), 530-533.
Ascaso, J. F., Pardo, S., Real, J. T., Lorente, R. I., Priego, A., & Carmena, R. (2003).
Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care, 26(12), 3320-3325.
Barter, P. (2005). The role of HDL-choleterol in preventing atherosclerotic disease. The European Society of Cardiology, 7, F4-F8.
Bergman, R. N., Finegood, D. T., & Ader, M. (1985). Asessment of insulin sensitivity in vivo. Endocrine Reviews, 6, 45-86.
Bloomgarden, Z. T. (2003). American association of clinical endocrinologists(AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC. Diabetes Care, 26(4), 1297-1303.
Bruce, C. R., & Hawley, J. A. (2004). Improvements in insulin resistance with aerobic exercise training: a lipocentric approach. Medicine and Science in Sports and Exercise, 36(7), 1196-1201.
Beghin, I., Cap, M., & Dujarein, B. (1988). A guide to nutritional assessment. Geneva WHO.
Caterson, I. D. (1990). Management strategies for weight control, eating, exercise and behavior. Drugs, 39 (suppl 3), 20-32.
Davidson, M. B. (1979). The effect of aging on carbohydrate metabolism: a review of the English literature and practicial approach to the diagnosis of diabetes mellitus in the elderly. Metabolism, 28, 688-705.
Dandona, P., Aljada, A., & Bandyopadhyay, A. (2004). Inflammation: the link between insulin resistance, obesity and diabetes. Trends in Immunology, 25(1), 4-7.
DeFronzo, R. A. (1988). Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes, 37(6), 667-687.
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005). The metabolic syndrome. The Lancet, 365(9468), 1415-1428.
Farese, R. V., Sajan, M. P., & Standaert, M. L. (2005). Insulin-sensitive protein kinases (a typical protein kinase C and protein kinase B/Akt): actions and defects in obesity and Type II diabetes. Experimental Biology and Medicine, 230(9), 593-605.
Feinleib, M. (1985). Epidemiology of obesity in relation to health hazards. Annal of Internayional Medicine, 103, 1019-24.
Fruhbeck, G., Gomez-Ambrosi, J., Muruzabal, F. J., & Burrell, M. A. (1985). The adipocyte:
a model for integration of endocrin and metabolic signaling in energy metabolism regulation. American Journal of Physiology. Endocrinology and Metabolism, 280, E827-47.
Fontbonne, A., Eschwege, E., Cambien, F., Richard, J. L., Ducimetiere, P., Thibult, N., et al.
(1989). Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia, 32(5), 300-304.
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002). Prevalence of the metabolic syndrome among U. S. adults: Findings from the third national health and nutrition examination survey. The Journal of the American Medical Association, 287(3), 356-359.
Ginsberg, H. N. (2000). Insulin resistance and cardiovascular disease. The Journal of Clinical Investigation, 106(4), 453-458.
Grundy, S. M., Brewer, H. B., Jr., Cleeman, J. I., Smith, S. C., Jr., Lenfant, C., & for the Conference, P. (2004). Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation, 109(3), 433-438.
Greenberg, A. S., & Obin, M. S. (2006). Obesity and the role of adipose tissue in inflammation and metabolism. The American Journal of Clinical Nutrition, 83(2), 461S-465S.
Henry, R. R., & Mudaliar, S. (2003). Obesity and TypeⅡ Diabetes Mellitus. In R. H. Eckel (Ed.), Obesity Mechanisms and Clinical Management(pp. 229-272). Philadelphia, USA:
Lippincott William & Wilkins.
Hrebicek, J., Janout, V., Malincikova, J., Horakova, D., & Cizek, L. (2002). Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for
epidemiological assessment and prevention. American Journal of Physiology.
Endocrinology and Metabolism, 87(1), 144-.
Holloszy, J. O. (2005). Exercise-induced increase in muscle insulin sensitivity. Journal of Applied Physiology, 99(1), 338-343.
Ivy, J. L. (2004). Muscle insulin resistance amended with exercise training: role of GLUT4 expression. Medicine and Science in Sports and Exercise, 36(7), 1207-1211.
Isomaa, B., Almgren, P., Tuomi, T., et al. (2004). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24, 683-9.
Kasuga, M. (2006). Insulin resistance and pancreatic {beta} cell failure. The Journal of Clinical Investigation, 116(7), 1756-1760.
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., et al. (2000).
Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. American Journal of Physiology. Endocrinology and Metabolism, 85(7), 2402-2410.
Kahn, S. E., Larson, V. G., Schwartz, R. S., Beard, J. C., Cain, K. C., Fellinham, G. W., Stratton, J. R., Cerqueira, M. D., & Abrass, I. B. (1992). Exercise training delineates the
importance of B-cell dysfuntion to the glucose intolerance of human aging. The Journal of Clinical Endocrinology and Metabolism, 74, 1336-1342.
Kendall, D. M., & Harmel, A. P. (2002). The metabolic syndrome, type 2 diabetes, and cardiovascular disease: Understanding the role of insulin resistance. American Journal of Managed Care, 8(20), S635-S653.
Ko, G. T., Cockram, C. S., Chow, C. C., et al. (2005). High prevalence of metabolic syndrome in Hong Kong Chinese-comparison of three diagnostic criteria. Diabetes Research and Clinical Practice, 69, 160-8.
Krook, A., Wallberg-Henriksson, H., & Zierath, J. (2004). Sending the signal: Molecular mechanisms regulating glucose uptake. Medicine and Science in Sports and Exercise, 36(7), 1212-1217.
Kristina, M. Utzschneider., Darcy, B. Carr., Suzanne, M. Barsness., Steven, E. Kahn., &
Robert, S. Schwartz. (2004). Diet-induced weight loss is associated with an improvement in β-cell function in older men. The Journal of Clinical Endocrinology and Metabolism, 89(6), 2704-2710.
Lakka, H. M., Laaksonen, D. E., Lakka, T. A. et al. (2002). The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. The Journal of the American Medical Association, 288, 2709-16.
Long, Y. C., & Zierath, J. R. (2006). AMP-activated protein kinase signaling in metabolic regulation. Journal of Clinical Investigation, 116(7), 1776-1783.
Ma, G. S., Li, Y. P., Hu, X. Q., Cui, Z. H., Yang, X. G., & Chen, C. M. (2006). Report on childhood obesity in China(2). Verification of BMI classification reference for overweight and obesity in Chinese children and adolescents. Biomedical ＆ Environmental Sciences, 19, 1-7.
McFarlane, S. I., Banerji, M., & Sowers, J. R. (2001). Insulin resistance and cardiovascular disease. The Journal of Clinical Endocrinology and Metabolism, 86(2), 713-718.
McAuley, K. A., Williams, S. M., Mann, J. I., Walker, R. J., Lewis-Barned, N. J., Temple, L.
A., et al. (2001). Diagnosing insulin resistance in the general population. Diabetes Care, 24(3), 460-464.
Papadopoulou-Alataki, E. et al. (2004). Clinical and biochemical manifestations of syndrome X in obese children. European Journal of Pediatrics, 63, 573-9.
Paolisso, G., Gambardella, A., Amato, L., Tortoriello, R., D’Amore, A., Varricchio, M., &
D’Onofrio, F. (1995). Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subject. Diabetologia, 38, 1295-1299.
Pessin, J. E., & Saltiel, A. R. (2000). Signaling pathways in insulin action: molecular targets of insulin resistance. The Journal of Clinical Investigation, 106(2), 165-169.
Raymond, I. Fink., Orville, G. Kolterman., Jennifer, Griffin., & Jerrold, M. Olefsky. (1983).
Mechanism of insulin resistance in aging. The Journal of Clinical Investigation, 71, 1523-1535.
Rhodes, C. J., White, M. F. (2002). Molecular insights into insulin action and secretion.
European Journal of Clinical Investigation, 32(suppl. 3), 3-13.
Ritz-Laser, B., Meda, P., Constant, I., Klages, N., Carollais, A., Morales, A., Magnan, C., Ktorza, A., & Philippe, J. (1999). Glucose-induced preproinsulin gene expression is inhibited by the free fatty acid palmitate. Endocrinology, 140, 4005-4014.
Reaven, G. M. (1988). Role of insulin resistance in human disease. Diabetes, 37(12), 1595 -1607.
Recasens, M., Ricart, W., & Fernandez-Real, J. (2004). Obesity and inflammation. Revista de Medicina de la Universidad de Navarra, 48(2), 49-54.
Saltiel, A. R. (2000). The molecular and physiological basis ofinsulin resistance: emerging implications for metabolic andcardiovascular diseases. Journal of Clinical Investigation, 106(2), 163-164.
Shoelson, S. E., Lee, J., & Goldfine, A. B. (2000). Inflammation and insulin resistance. The Journal of Clinical Investigation, 116(7), 1793-1801.
Short, K. R., Vittone, J. L., Bigelow, M. L., Proctor, D. N., Rizza, R. A., Coenen-Schimke, J.
M., et al (2003). Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes, 52(8), 1888-1896.
Swales, J. D., Sever, P. S., & Peart, S. T. (1991). Clinical atlas of hypertension. Singapore.
Gower Medical Publishing.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. (2002). Circulation, 106(25), 3143-3421.
Weiss, R., Dziura, J., Burgert, T.S., et al. (2004). Obesity and the metabolic syndrome in children and adolescents. The New England Journal of Medicine, 350, 2362-74.
Wang, P. A. (1988). Rowe on insulin synthesis and secretion. Differential effects on preproinsulin messenger RNA levels, proinsulin biosynthesis, and secretion of newly made and preformed insulin in the rat. The Journal of Clinical Investigation, 81, 176-84.